Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding an additional COVID-19 dose for highest risk people in 2023.
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023.
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years (Pfizer 6 months to 4 years).
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years.
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November 2022.
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine.
Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged 6 months to under 5 years who have an increased risk of getting very sick from COVID-19. The COVID-19 vaccination will help reduce this risk.
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine.
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 7 September 2022. ATAGI are now meeting every fortnight on COVID-19 related issues.
COVID-19 vaccination will be available from 5 September for at risk children aged from 6 months to under 5 years at the ACT Government’s Weston Creek vaccination clinic.
From 5 September 2022, children aged 6 months to under 5 years who are most at risk of severe disease will be able get the Spikevax (Moderna) COVID-19 vaccine.
ATAGI has released updated recommendations for a winter COVID-19 vaccination dose (second booster / fourth dose).
